Endoskopische Diagnostik und Therapie von Ösophaguskarzinomen

Endoskopischen Verfahren kommt sowohl in der Diagnostik des Ösophaguskarzinoms als auch in der Therapie von Frühformen entscheidende Bedeutung zu. Dieser Beitrag gibt eine aktuelle Übersicht.

• Literatur

• 1 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus, Langversion 1.0. 2015
• 2 Koop H. et al. S2k-Leitlinie: Gastroösophageale Refluxkrankheit unter Federführung der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). Version 14. 2014
• 3 Tholoor S. et al. Acetic acid chromoendoscopy in Barrett’s esophagus surveillance is superior to the standardized ransom biopsy protocol: results from a large cohort study (with video). Gastrointest Endosc 2014; 80: 417-424
• 4 Sharma P. et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomized controlled trial. Gut 2013; 62: 15-21
• 5 Dubuc J. et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 2006; 38: 690-695
• 6 Oyama T. et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessels morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus 2017; 14: 105-112
• 7 Hölscher A. et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 2011; 254: 802-808
• 8 Li B. et al. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2013; 146: 1198-1203
• 9 Ell C. et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 2007; 65: 3-10
• 10 Pech O. et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grad intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008; 57: 1200-1206
• 11 Fujita H. et al. Treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001; 25: 424
• 12 Pech O. et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterol 2014; 146: 652-660
• 13 Manner H. et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc 2015; 29: 1888-1896
• 14 Birkmeyer J. et al. Hopital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
• 15 Birkmeyer J. et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-2127
• 16 Probst A. et al. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 2015; 47: 113-121
• 17 Pimentel-Nunes P. et al. Endoskopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854
• 18 Phoa KN. et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013; 145: 96-104
• 19 Cao Y. et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastroinstestinal tract. Endocscopy 2009; 41: 751-757
• 20 Ishihara R. et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008; 68: 1066-1072